Leland Gershell

Leland Gershell

Analyst-Equity at Oppenheimer & Co., Inc. (Broker)

52 year
Finance
Health Technology
Consumer Services

Profile

Dr. Leland Gershell is a Managing Director & Senior Analyst at Oppenheimer & Co., Inc. He covers BioPharmaceuticals.
Prior to joining Oppenheimer, Dr. Gershell was Chief Financial Officer of Capricor Therapeutics and Tonix Pharmaceuticals.
He also has both sell-side and buy-side experience and began his career on Cowen's biotechnology research team, where he provided sole coverage focused in the small and mid-cap segment.
Dr. Gershell earned his M.D.
and Ph.D.
in Organic Chemistry from Columbia University and his B.A.
magna cum laude in Chemistry and Asian Studies from Dartmouth College.

Leland Gershell active positions

CompaniesPositionStart
Analyst-Equity 2018-01-31
All active positions of Leland Gershell

Former positions of Leland Gershell

CompaniesPositionEnd
CAPRICOR THERAPEUTICS, INC. Director of Finance/CFO 2017-12-31
TONIX PHARMACEUTICALS HOLDING CORP. Director of Finance/CFO 2016-01-07
Analyst-Equity 2012-03-30
Corporate Officer/Principal 2010-09-30
Analyst-Equity 2010-05-30
See the detail of Leland Gershell's experience

Training of Leland Gershell

The Trustees of Columbia University in The City of New York Doctorate Degree
Dartmouth College Undergraduate Degree
Columbia University Vagelos College of Physicians & Surgeons Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Leland Gershell's experience

Connections

99

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
TONIX PHARMACEUTICALS HOLDING CORP.

Health Technology

CAPRICOR THERAPEUTICS, INC.

Health Technology

Private companies6

Finance

Health Technology

Finance

Finance

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Leland Gershell